| 產(chǎn)品編號 | bsm-51016M |
| 英文名稱 | Mouse Anti-phospho-FXYD1 (Ser88) antibody |
| 中文名稱 | 磷酸化FXYD1單克隆抗體 |
| 別 名 | FXYD domain containing ion transport regulator 1; Phospholemman; PLM; PLM_MOUSE; PLM_HUMAN; |
| 研究領(lǐng)域 | 腫瘤 免疫學 神經(jīng)生物學 通道蛋白 新陳代謝 |
| 抗體來源 | Mouse |
| 克隆類型 | Monoclonal |
| 克 隆 號 | 10E2 |
| 交叉反應 | (predicted: Mouse) |
| 產(chǎn)品應用 | WB=1:500-1000
not yet tested in other applications. optimal dilutions/concentrations should be determined by the end user. |
| 理論分子量 | 10kDa |
| 細胞定位 | 細胞膜 |
| 性 狀 | Liquid |
| 濃 度 | 1mg/ml |
| 免 疫 原 | KLH conjugated synthesised phosphopeptide derived from mouse FXYD1 around the phosphorylation site of Ser88: RL(p-S)SR |
| 亞 型 | IgG1 |
| 純化方法 | affinity purified by Protein G |
| 緩 沖 液 | 0.01M TBS (pH7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol. |
| 保存條件 | Shipped at 4℃. Store at -20℃ for one year. Avoid repeated freeze/thaw cycles. |
| 注意事項 | This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications. |
| PubMed | PubMed |
| 產(chǎn)品介紹 |
PLM (FXYD1)is a member of a family of small membrane proteins that share a 35-amino acid signature sequence domain, beginning with the sequence PFXYD and containing 7 invariant and 6 highly conserved amino acids. FXYD2, also known as the gamma subunit of the Na,K-ATPase, regulates the properties of that enzyme. FXYD1 (phospholemman), FXYD2 (gamma), FXYD3 (MAT-8), FXYD4 (CHIF), and FXYD5 (RIC) have been shown to induce channel activity in experimental expression systems. PLM may be phosphorylated by several kinases, including protein kinase A, protein kinase C, NIMA kinase, and myotonic dystrophy kinase. It is thought to form an ion channel or regulate ion channel activity. Function: May have a functional role in muscle contraction. Induces a hyperpolarization-activated chloride current when exogenously expressed. Subcellular Location: Membrane; Single-pass type I membrane protein. Tissue Specificity: placenta, lung, liver, pancreas, uterus, bladder, prostate, small intestine and colon with mucosal lining. Very low levels in kidney, colon and small intestine without mucosa, prostate without endothelial lining, spleen, and testis. Post-translational modifications: Major plasma membrane substrate for cAMP-dependent protein kinase (PK-A) and protein kinase C (PK-C) in several different tissues. Phosphorylated in response to insulin and adrenergic stimulation. May be phosphorylated by DMPK (By similarity). Palmitoylation increases half-life and stability, it is enhanced upon phosphorylation at Ser-88 by PKA. Similarity: Belongs to the FXYD family. SWISS: Q9Z239 Gene ID: 56188 Database links: Entrez Gene: 5348 Human Entrez Gene: 56188 Mouse Omim: 602359 Human SwissProt: O00168 Human SwissProt: Q9Z239 Mouse Unigene: 442498 Human |
| 1、抗體溶解方法 | |
| 2、抗體修復方式 | |
| 3、常用試劑的配制 | |
| 4、免疫組化操作步驟 | |
| 5、免疫組化問題解答 | |
| 6、Western Blotting 操作步驟 | |
| 7、Western Blotting 問題解答 | |
| 8、關(guān)于肽鏈的設(shè)計 | |
| 9、多肽的溶解與保存 | |
| 10、酶標抗體效價測定程序 | |
